Other News

OMRON Healthcare Remote Patient Monitoring Services Win “Best of” Honors at CES 2022

Hypertension Plus in the U.K., VitalSight™ in the U.S., Recognized as Outstanding Health Technology at World’s Largest Innovation Show HOOFDDORP, Netherlands–(BUSINESS WIRE)–OMRON Healthcare, Inc., the global leader in remote blood pressure monitoring and personal health technology, spotlighted its new remote patient monitoring services at the 2022 Consumer Electronics Show (CES) and […]

Casana Closes $30 Million Series B Funding to Accelerate Development of Novel Effortless Home Health Monitoring

Casana’s Series B led by Morningside. Matrix Partners and Series A investors General Catalyst and Outsiders Fund join the round. The Heart Seat, an effortless, patient-centered health monitoring technology built into a toilet seat, is Casana’s first product. ROCHESTER, N.Y., Jan. 21, 2022 (GLOBE NEWSWIRE) — Casana, a healthcare technology […]

Alnylam Presents Positive 18-Month Results from HELIOS-A Phase 3 Study of Investigational Vutrisiran in Patients with hATTR Amyloidosis with Polyneuropathy

– Vutrisiran Met All 18 Month Secondary Endpoints, Including Statistically Significant Improvements in Neuropathy Impairment, Quality of Life (QoL), Gait Speed, Nutritional Status and Overall Disability, Relative to External Placebo – – Vutrisiran Continued to Demonstrate Halting or Reversal of Polyneuropathy, with Improvements in Neuropathy Impairment and QoL Relative to […]

United Therapeutics Corporation Announces Historic Achievements in its Xenotransplantation Programs

UKidney™ procedure data published in the American Journal of Transplantation; the first such data published in a peer-reviewed journal UHeart™ recipient patient reaches a two-week milestone post-transplant UThymoKidney™ procedure represents a historic first preclinical human model study SILVER SPRING, Md. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–United Therapeutics Corporation (UT) (Nasdaq: UTHR), […]

Athersys Appoints Experienced Commercial Leader, Daniel A. Camardo, to Chief Executive Officer

Camardo to lead Company’s transition to a commercial-stage company CLEVELAND–(BUSINESS WIRE)–Athersys, Inc. (Nasdaq: ATHX), an international, late-stage, regenerative medicine company, announced today the appointment of Daniel A. Camardo as the Company’s Chief Executive Officer, effective February 14, 2022. Mr. Camardo is a senior pharmaceutical and biotech executive with more than […]

SUCCESSFUL FIRST-IN-HUMAN USE OF BENDIT21 NEUROVASCULAR CATHETER PERFORMED AT THE UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER

TEL AVIV, Israel, Jan. 20, 2022 /PRNewswire/ — BENDIT Technologies, a company focused on the development of steerable microcatheters, announced today the successful first use in the USA of the BENDIT21 neuro catheter in a life-saving treatment. The case involved a 57-year-old female patient who had been suffering for years from an inoperable symptomatic […]

Cardiovascular Systems, Inc. and OrbusNeich Announce FDA PMA Approval of Scoreflex® Scoring Balloon

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today, along with OrbusNeich Medical Company Ltd (OrbusNeich®), announced FDA PMA approval of OrbusNeich’s Scoreflex® NC Scoring Percutaneous Transluminal Coronary Angioplasty (PTCA) Catheter […]

Neovasc Announces Publication Supporting the Neovasc Reducer™ Device

VANCOUVER and MINNEAPOLIS, Jan. 20, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc, Inc. (Neovasc or the Company) (NASDAQ, TSX: NVCN) today announced the publication of an article entitled, “The Effectiveness of CS Reducer for the Treatment of Refractory Angina – a Meta-Analysis” in the Canadian Journal of Cardiology. The article’s lead author and senior authors are […]

Ra Medical Systems CEO Issues Letter to Stockholders

CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED) announces that Chief Executive Officer Will McGuire has issued the following Letter to Stockholders: To My Fellow Stockholders: I’m very proud of the Ra Medical team’s significant progress in implementing engineering enhancements to improve the performance and extend the shelf life of […]

Philips supports the American Heart Association’s efforts to raise awareness of cardiovascular implantable electronic device (CIED) infections, promote guideline adherence, and improve patient survival rates

January 19, 2021 The American Heart Association’s multi-year initiative, supported by Philips, aims to bring forward the latest education and clinical data to increase awareness for providers and patients in the pursuit of guideline-driven CIED care Every year in the USA less than 30% of patients with CIED infections are […]